|
Hepatitis C: An Overview
Prevalence | Incidence | Demographics | Natural History | Transmission
Prevention | HCV Testing | Treatment | What You Need To Know
Transmission
How is hepatitis C being transmitted?
- Routes of Transmission Pie Chart
- Injecting Drug Use
- Accounts for 60 percent of HCV transmission
- Accounts for two-thirds of new infections
- Highly efficient mode of transmission
- Prevalence in injecting drugs using populations is high
- Rapidly acquired after first injection
Prevalence of HCV and HIV in IDUs
Location |
Year |
HCV |
HIV |
Amsterdam |
1991 |
66% |
33% |
Geneva |
1992 |
80% |
32% |
Baltimore |
1994 |
90% |
25% |
Seattle |
1999 |
82% |
2% |
Rural UK |
2000 |
56% |
14% |
S. China |
2003 |
71% |
17% |
Vancouver |
2004 |
44% |
19% |
- Studies of Young or New Injectors
- Baltimore (Thomas, et. al): Reported 80 percent prevalence in subjects acknowledging two years of injection drug use or less.
- Chicago and Suburbs (Thorpe, et. al):
- Reported 27 percent prevalence in subjects age 18 to 30
- Reported 15 percent prevalence in subjects acknowledging two years of injection drug use or less.
- Studies of Young or New Injectors
- Seattle (Hagan et. al):
- Reported 41 percent antibody prevalence in subjects acknowledging drug use for two years or less at time of enrollment.
- Mean time to seroconversion:
- 0.6 years for those positive at enrollment
- 5.4 years for those negative at enrollment who later seroconverted
- 3.4 years weighted average time to seroconversion
- Factors Associated with Infection
- Years of injecting
- Frequency of injection
- Being a young/new injecting drug user
- Sharing syringes
- Sharing cotton/cookers
- Backloading
- Sexual Transmission
- 15 percent of HCV infection
- However, sex is an inefficient mode of transmission
- Long-Term Spouses (CDC)
- A low prevalence of HCV infection has been reported by studies of long-term spouses of patients with chronic HCV infection who had no other risk factors for infection.
- Five of these studies have been conducted in the United States, involving 30-85 partners each, in which average prevalence was 1.5% (range: 0% to 4.4%)
- Long-Term Prospective Study (Vandelli et. al.)
- Enrolled anti-HCV negative partners of HCV positive individuals.
- 776 partners completed a ten-year follow-up.
- Three spouses acquired HCV during follow-up.
- All had other risk factors and/or follow-up testing showed genotype/strain discordant with that of spouse.
- Sexual Transmission
- Risk higher among those with multiple partners and history of sexually transmitted disease
- Prevalence found to average 5 percent among STD clinic patients with no history of injection drug use.
- Factors associated with positivity
- Greater number of sex partners
- History of STDs
- Failure to use a condom
- Transfusion
- 1990
- Routine testing of donors was initiated.
- Risk was approximately 1.5% per recipient or approximately 0.2% per unit transfused.
- July 1992
- More sensitive testing was implemented.
- Reducing risk for infection to 0.001% per unit transfused.
- 2005
- Current risk for transfusion-associated hepatitis C is 1 per 2 million units transfused.
- Blood Clotting Factor
- Used to treat individuals with hemophilia.
- High risk of infection prior to the use of virus inactivation procedures that were introduced in 1985 and 1987.
- Prevalence is greater than 90 percent in hemophiliacs treated with these products before inactivation.
- Solid Organ Transplants
- Occupational
- Occupational exposure is inefficient.
- In one study that evaluated risk factors for infection, a history of unintentional needle-stick injury was the only occupational risk factor independently associated with HCV infection.
- Average incidence 1.8 percent following needle stick from HCV-positive source.
- Prevalence among health care workers is 1 to 2 percent.
- Nosocomial Transmission
- Rarely reported in the United States, other than in chronic hemodialysis settings.
- Prevalence of anti-HCV positivity among chronic hemodialysis patients averages 10%.
- Studies have documented an association between anti-HCV positivity and increasing years on dialysis.
- Most likely due to incorrect implementation of infection-control practices.
- Perinatal
- Five percent of infected mothers transmit the virus to their baby.
- Average rate of transmission is higher in women also infected with HIV – 17 percent.
- No difference seen between vaginal and cesarean births.
- Household Transmission
- Rare but not absent
- Could occur through percutaneous/mucosal exposure to blood
- Contaminated equipment for home therapies
- Theoretically through the sharing of personal items (I.e., toothbrushes, razors)
- No Known Risk
- In 10 percent of cases, no known risk is identified.
- Exposures in Other Settings (CDC)
- No data or insufficient data to show transmission through:
- Intranasal cocaine use
- Tattooing
- Piercing
|